HSPB1 and cancer: Clinically, HSP27 is highly expressed in many cancers including breast (Conroy et al., 1998), ovarian (Arts et al., 1999), prostate (Cornford et al., 2000) and others (Bruey et al., 2000) and is associated with aggressive tumour behaviour, metastasis and poor prognosis.